Medical oncologist Paul Sabbatini discusses advancing cancer treatment through clinical research, Physician-in-Chief José Baselga explains the latest findings in targeted therapy for breast cancer, and researchers report on how a single early PSA test can predict a man’s risk for aggressive prostate cancer.
View current issue now »
Subscribe to Our E-newsletter
Get the latest information about cancer
- March 2013
Gynecology Service Chief Richard Barakat comments on a study indicating that women with ovarian cancer benefit from treatment at high-volume centers, researchers eradicate cancer in five patients with acute lymphoblastic leukemia, and scientists discover a molecule that targets proteins inside cancer cells.
- February 2013
Physician-scientist Charles Sawyers is a recipient of the inaugural $3 million Breakthrough Prize in Life Sciences, medical oncologist Mark Kris discusses Memorial Sloan-Kettering’s partnership with IBM Watson and WellPoint to help assist medical professionals, and Good Morning America’s Robin Roberts returns to work after a stem cell transplant.
- January 2013
Memorial Sloan-Kettering projects are listed among 2012’s top cancer advances, Stand Up To Cancer names two physician-scientists to an Immunology “Dream Team,” and a behavioral psychologist discusses cognitive changes associated with cancer treatment.
- December 2012
A breast cancer specialist discusses new findings on extending tamoxifen for breast cancer, President Obama names Memorial Sloan-Kettering physician-scientist Charles Sawyers to the National Cancer Advisory Board, and our experts share the latest information about prostate cancer treatment.
- November 2012
Memorial Sloan-Kettering’s Integrative Medicine Service presents a new About Herbs mobile app, researchers synthesize the vital biological molecule erythropoietin for the first time, and experts discuss managing anxiety about medical scans and procedures.
- September 2012
Internationally recognized physician-scientist José Baselga (left) will join Memorial Sloan-Kettering from Massachusetts General Hospital, Memorial Sloan-Kettering announces plans to build a new outpatient cancer treatment facility, and a targeted drug for prostate cancer receives FDA approval.
- August 2012
Memorial Sloan-Kettering unveils Meet Our Experts tab on Facebook, stem cell transplant specialists discuss the procedure and becoming a donor, and two cancer survivors share their experiences.
- July 2012
Memorial Sloan-Kettering launches On Cancer blog, doctors start a clinical trial involving stem cell therapy for beta-thalassemia, and the Pediatric Day Hospital Director talks about caring for children with cancer.
- June 2012
Prostate cancer experts share their perspective on new PSA screening recommendations, an ICU nurse practitioner talks about her work, and our experts share the latest information about lung cancer treatment.
- May 2012
A pulmonary specialist talks about new findings on lung cancer CT screening, two of our investigates are named to the National Academy of Sciences, and the Bridges newsletter for cancer survivors marks its fifth year of publication.
- April 2012
The Department of Surgery Chair discusses surgery’s vital role in treating cancer, industry experts nominate mskcc.org for a Webby Award, and four surgeons describe what motivates them in their work.
- March 2012
Doctors describe training the next generation of cancer specialists, Memorial Sloan-Kettering and IBM announce a collaboration using Watson technology, and researchers report pediatric cancer findings.
- February 2012
Scientists and physicians describe the promise of treating cancer with cell-based therapies, Cycle for Survival participants break fundraising records, and a neurosurgeon talks about innovations at the Spine Tumor Center.
- January 2012
Experts describe the development and commercialization of research discoveries to generate better cancer treatments, the American Society of Clinical Oncology elects medical oncologist Clifford Hudis as president, and our experts share the latest information about melanoma treatment.